Meth Statistics
About 2.7 million Americans aged 12 or older reported past-year methamphetamine use in 2025, and about 1.8 million met survey criteria for methamphetamine use disorder. Explore what the research shows about use, overdose deaths, demographic patterns, and treatment.[14][15]
Battling addiction & ready for help?
Meth Use, Addiction, and Overdose Statistics
About 2.7 million people aged 12 or older used methamphetamine in the past year in 2025, representing 0.9% of the U.S. civilian, noninstitutionalized population in that age range.[14] These latest national meth statistics describe past-year use, not how many people use meth every day or have an addiction.[14]
The trend depends on the measure. Meth use increased during the second half of the 2010s, but national use prevalence showed no statistically significant change from 2021 through 2025.[1][14][2] Overdose deaths rose substantially over earlier years, although CDC reported provisional declines in 2024. Understanding those differences gives a clearer picture than saying every measure is still rising.[1][14][2]
- About 2.7 million people aged 12 or older reported past-year meth use in 2025.[14] That was 0.9% of the surveyed U.S. population.[14]
- About 1.8 million people met survey criteria for methamphetamine use disorder in 2025.[15] The 2025 estimate for methamphetamine use disorder was 0.6% of people aged 12 or older.[15]
- The age-adjusted psychostimulant overdose death rate rose from 3.9 to 10.4 per 100,000 between 2018 and 2023.[2] This category primarily involves methamphetamine but is not meth-only.[2]
- About 32,000 adolescents aged 12 to 17 reported past-year meth use in 2025.[14] That was 0.1% of adolescents, substantially below the rate among adults aged 26 or older.[14]
- Effective treatment is available. Contingency management has the strongest evidence for stimulant use disorder, and other behavioral treatments have some support, especially alongside contingency management. Evidence for cognitive behavioral therapy alone is mixed; it focuses on practical recovery skills.[2][18]
Meth Use in the United States by the Numbers
How Many Americans Use Methamphetamine?
The 2025 National Survey on Drug Use and Health, or NSDUH, estimated that 2.7 million people aged 12 or older used methamphetamine during the previous year.[14] The survey represents the civilian, noninstitutionalized U.S. population, rather than everyone living in the country.[14]
Past-year use means someone reported using meth at some point during that period. It does not establish daily use, injection, or addiction. The national survey figures presented here also do not provide a separate count specifically for crystal meth use.[14]
How Many People Are Addicted to Meth?
An estimated 1.807 million people aged 12 or older met survey criteria for past-year methamphetamine use disorder in 2025, or 0.6% of that population.[15] This is the relevant national estimate for meth addiction, rather than the larger number reporting any use.[15]
Methamphetamine use disorder is assessed using DSM-5 criteria. The estimate reflects survey responses meeting those criteria, not a count of people who received a diagnosis in treatment. Understanding meth addiction therefore requires looking at problems related to use, not simply whether someone has used the drug.[15]
Use estimates count people reporting use. Use-disorder estimates assess diagnostic criteria. Treatment admissions count entries into care, which can include repeated admissions. Death records identify substances involved in fatal overdoses. These measures answer different questions and should not be treated as interchangeable.[14][15][9][2]
Is Meth Use Increasing or Decreasing?
National past-year meth use prevalence showed no statistically significant change from 2021 to 2025, overall or within the age groups reported by SAMHSA. That differs from the historical increase among adults aged 18 to 64 between 2015 and 2019.[14][1]
The older and newer survey series cannot be directly joined. NSDUH introduced combined web and in-person data collection, and SAMHSA says estimates from 2021 onward are not comparable with estimates from 2020 or earlier. Comparing the older adult estimate with the newer age-12-and-older estimate would also mix populations.[14]
Historical Meth Use and Addiction Trends
From 2015 to 2019, past-year meth use among adults aged 18 to 64 increased from 1.4 million to 2.0 million, a 43% increase.[1] Frequent use and methamphetamine use disorder without injection grew faster than the overall number reporting use.[1]
| Methamphetamine measure | 2015 | 2019 | Change |
|---|---|---|---|
| Past-year use | 1.4 million | 2.0 million | +43% |
| Frequent use | 615,000 | 1,021,000 | +66% |
| Both meth and cocaine use during the year | 402,000 | 645,000 | +60% |
| Use disorder without injection | 397,000 | 815,000 | +105% |
These findings show that the change was not limited to more people trying meth. More people reported frequent use and a use disorder. However, frequent use does not necessarily mean daily use, and reporting both meth and cocaine during a year does not establish that the drugs were taken together.[1]
Meth Overdose Deaths and the Fourth Wave
CDC’s 2025 report cites 34,855 U.S. overdose deaths involving psychostimulants with abuse potential in 2023.[2] This death-record category consists largely of methamphetamine but includes other amphetamines, so it is not an exact count of meth-only deaths.[2]
Methamphetamine Overdose Deaths Over Time
Earlier research found that overdose deaths involving psychostimulants other than cocaine increased from 5,526 in 2015 to 15,489 in 2019, a 180% increase.[1] These mortality figures are separate from the study’s survey estimates for adults aged 18 to 64 and should not be assumed to have the same age restriction.[1]
In CDC’s later national analysis, the age-adjusted psychostimulant overdose death rate increased from 3.9 per 100,000 people in 2018 to 10.4 in 2023.[2] Age adjustment helps researchers compare rates without differences in the population’s age distribution driving the comparison.[2]
| Drug category | 2018 | 2023 |
|---|---|---|
| Psychostimulants, primarily methamphetamine | 3.9 | 10.4 |
| Cocaine | 4.5 | 8.6 |
Across a longer historical period, a study of U.S. residents aged 15 to 74 found a roughly fiftyfold increase in the age-adjusted methamphetamine-related mortality rate from 1999 to 2021. That finding describes a rate, not a fiftyfold increase in the number of deaths across all ages.[4]
The longer-term rise was substantial, but it was not uninterrupted. CDC’s report also noted provisional declines in stimulant-involved overdose deaths in 2024, with deaths still well above 2011 levels. The report does not provide final full-year death counts for 2024 or later.[2]
Meth, Fentanyl, and Overdose Deaths
The “fourth wave” describes the growing involvement of fentanyl and stimulants in fatal overdoses. The share of all U.S. overdose deaths involving both rose from 0.6% in 2010 to 32.3% in 2021.[3] The stimulant category includes cocaine as well as methamphetamine; these are death statistics, not the percentage of people combining drugs.[3]
CDC’s State Unintentional Drug Overdose Reporting System provides a more detailed view. Its analysis included 309,274 unintentional or undetermined-intent overdose deaths during January 2021 through June 2024 across 49 states and Washington, D.[2]C. Jurisdictional coverage varied, so these figures should not be described as every U.S. overdose death.[2]
| Substances involved | Share of included deaths |
|---|---|
| Any stimulant | 59.0% |
| Methamphetamine | 31.2% |
| Both a stimulant and an opioid | 43.1% |
Among methamphetamine-involved deaths specifically, 68.8% also involved opioids.[2][4] A separate historical study of people aged 15 to 74 found that 61.2% of methamphetamine-related deaths involved heroin or fentanyl in 2021.[2][4] The percentages differ because the studies used different populations, periods, and drug definitions.[2][4]
Finding meth and an opioid in the same death does not prove the meth was contaminated. Both drugs can be involved after intentional co-use or exposure to mislabeled or contaminated products. Death records alone do not establish which happened.[2][19]
CDC noted that recent drug-checking programs rarely detected opioids in stimulant products, suggesting that intentional use of separate products contributed to deaths involving both. This is not evidence of zero contamination risk. It shows why prevention must address both unexpected exposure and intentional co-use within the wider stimulant epidemic.[2][19]
If you suspect a meth overdose, call 911. Give naloxone if opioids may be involved; it can reverse opioid effects but does not reverse stimulant toxicity. Follow the dispatcher’s instructions, including breathing support when needed, and do not delay emergency care while trying to identify the substances involved.[19]
Meth Harms Beyond Overdose
Meth-related harm is not limited to fatal overdose. Research also documents psychosis and cardiovascular complications, including heart failure. These findings support addressing mental and physical health alongside substance use rather than waiting for an overdose to seek care.[2][7][18]
Meth, Psychosis, and Aggression
Meth can cause paranoia, hallucinations, confusion, and agitation. Aggression can occur with large amounts, but these effects do not describe every person who uses meth. Criminal-justice involvement in survey data is an association, not proof that meth use or psychosis caused violent behavior.[18][1]
One study compared 70 hospitalized patients with methamphetamine-associated psychosis with 70 patients with primary schizophrenic psychosis.[6] Longer meth use was associated with longer psychosis duration, while earlier initiation was associated with greater symptom severity. These findings describe correlations in selected hospitalized patients, not proof of permanent brain injury in everyone who uses meth.[6]
Psychosis often improves after stimulant use stops, but symptoms can persist or recur. Renewed use, stress, and lack of sleep can trigger another episode after symptoms have resolved. Persistent symptoms deserve care rather than an assumption that they will disappear as soon as the drug wears off.[18]
Meth-Related Heart Failure Hospitalizations Increased
A national hospital-discharge study found that adult primary heart-failure hospitalizations with a secondary methamphetamine-related diagnosis increased from 547 in 2002 to 6,625 in 2014.[7] These admissions were concentrated on the West Coast.[7]
Patients in the methamphetamine-associated heart-failure group were younger, with a mean age of 48.9 compared with 72.4 for other heart-failure hospitalizations.[7] These are hospitalization records, not necessarily unique patients, and they do not tell us what percentage of everyone using meth will develop heart failure.[7]
Meth Use and Life Expectancy
These studies do not establish a single life expectancy for someone with meth addiction. Population death rates and hospital admissions cannot predict how many years an individual will live. They do show why cardiovascular health deserves attention: a medical visit can assess stimulant use, heart-related symptoms, and the need for further care.[2][7]
Meth Statistics by Age
Past-year meth use was highest among adults aged 26 or older in 2025, at 1.1%, compared with 0.4% among young adults aged 18 to 25 and 0.1% among adolescents aged 12 to 17.[14]
| Age group | Estimated people | Past-year use |
|---|---|---|
| 12 to 17 | 32,000 | 0.1% |
| 18 to 25 | 145,000 | 0.4% |
| 26 or older | 2.5 million | 1.1% |
How Many Teens Use Meth?
About 32,000 adolescents aged 12 to 17 reported past-year meth use in 2025.[14] The adolescent use percentage showed no statistically significant change from 2021 through 2025. A low population prevalence does not make an individual teen’s use unimportant, but it does mean adult treatment records should not be used to estimate teen use.[14]
Meth Use Patterns in Adulthood
An analysis of adults aged 18 to 64 using 2015–2019 survey data found that heterosexual and gay men aged 26 to 34 were more likely to report past-year meth use than their counterparts aged 21 to 25. The same age pattern was not found across every sexual-identity and gender group, so it should not be generalized to all adults.[8]
Meth Statistics by Sex and Gender
Meth Use Is Higher Among Males
A national survey analysis estimated past-year meth use in 2022 at 1.4% among males and 0.7% among females.[5] These are sex-specific estimates for that year, not the latest overall national use figures.[5]
The study examined a longer historical period, but the NSDUH methodology break limits direct comparisons between its earlier and later estimates. The same-year contrast is clearer evidence than treating the entire series as one continuously comparable trend.[5][14]
Women, Pregnancy, and Meth Treatment
In Los Angeles County treatment data from 2011, 2013, 2015, and 2017, women accounted for 43.3% of treatment episodes involving methamphetamine, compared with 33.6% for other drugs combined.[9] These are local treatment episodes, not national use prevalence or a count of unique women receiving care.[9]
Among pregnant people entering U.S. substance use treatment who used opioids, methamphetamine co-use increased from 2.8% to 6.1% between 2011 and 2023.[10] This treatment-admission finding does not describe all pregnant people. It highlights the need for care that addresses more than one substance and the social barriers affecting treatment.[10]
Meth Statistics by Race and Ethnicity
Race and ethnicity findings differ depending on whether researchers measure use disorder or overdose deaths. The fastest proportional increase in one measure is not necessarily the highest rate in another. Keeping those outcomes separate helps identify where prevention and treatment resources are needed.[1][2]
Meth Use Disorder Rose Sharply Among Black Adults
Between 2015 and 2019, adjusted prevalence of methamphetamine use disorder without injection increased more than tenfold among Black adults aged 18 to 64, from 0.06% to 0.64%.[1] It also increased among White and Hispanic adults. These are adjusted estimates for a specific use-disorder category, not raw rates of any meth use.[1]
| Race or ethnicity | 2015 | 2019 |
|---|---|---|
| Non-Hispanic Black adults | 0.06% | 0.64% |
| Non-Hispanic White adults | 0.28% | 0.78% |
| Hispanic adults | 0.39% | 0.82% |
A large relative increase from a low starting point is not the same as having the highest prevalence. The study also identified associations with housing instability, lower income, lack of insurance, and co-occurring health conditions, supporting attention to practical barriers to care rather than assumptions about individuals based on race.[1]
Meth-Related Death Rates Among American Indian and Alaska Native People
Non-Hispanic American Indian and Alaska Native people had the highest psychostimulant overdose death rate among the groups reported in CDC’s analysis. Their age-adjusted rate rose from 11.0 per 100,000 in 2018 to 32.9 in 2023.[2] These rates cover unintentional and undetermined-intent deaths involving psychostimulants, primarily methamphetamine.[2]
CDC noted that meth use prevalence in this population remained relatively stable during that period. Rising mortality therefore should not automatically be described as rising use. Changes in drug markets and unequal access to health care and substance use treatment are among the possible explanations discussed in the report.[2]
Meth Use in LGBTQ Communities
Sexual-Minority Adults Report Higher Meth Use
In a national analysis of adults aged 18 to 64 using 2015–2019 data, lesbian, gay, and bisexual adults reported higher past-year meth use than heterosexual adults. The analysis concerned sexual identity; it did not provide a separate estimate for every gender identity or establish that identity causes substance use.[8]
A different analysis examined adjusted prevalence of methamphetamine use disorder without injection. It found increases across the sexual-identity groups below. Because this is a narrower outcome than any meth use, its percentages should not be substituted for overall use prevalence.[1]
| Group | 2015 | 2019 |
|---|---|---|
| Gay or bisexual men | 0.29% | 0.80% |
| Heterosexual men | 0.29% | 0.79% |
| Heterosexual women | 0.24% | 0.74% |
| Lesbian or bisexual women | 0.21% | 0.71% |
Meth Injection and HIV Risk
National survey research identified HIV/AIDS and hepatitis B or C among health conditions associated with meth use, while also examining injection drug use as a higher-risk pattern. Those associations do not establish how an individual acquired an infection, and methamphetamine use disorder can occur without injection.[1]
Care should address these overlapping needs without making assumptions about someone’s identity. SAMHSA recommends harm-reduction services, including syringe programs, for people with stimulant use disorders who are not ready for formal treatment. Support does not have to wait until someone is ready to stop completely.[18]
Meth Statistics by Region
Regional Patterns in Meth-Related Deaths
By 2021, methamphetamine was the predominant substance co-involved with fentanyl in fatal overdoses throughout the West and in most states in the South and Midwest. In the Northeast, cocaine-fentanyl co-involvement predominated. These findings describe regional overdose patterns, not the percentage of residents using meth.[3]
Which States Have the Highest Meth Use?
The regional death studies do not establish a current state-by-state ranking of meth use. A state with many meth-involved deaths does not necessarily have the highest use prevalence: deaths also reflect other substances, patterns of use, and access to care. A reliable use ranking requires comparable state survey estimates from the same period.[3][2]
Rural Communities Face Distinct Meth-Related Needs
An Alabama study examined Medicaid claims among adults older than 18 from 2015 through 2020. Recorded methamphetamine-related use rates increased in 51 of 67 counties, and 10 counties had increases exceeding 100%. The findings suggested greater use in rural areas, but they apply to this Medicaid population, not all Alabama residents or rural America generally.[12]
National survey research also found that past-month meth use increased from 9% to 44% between 2015 and 2019 among people reporting past-month heroin use.[13] Rural residence was associated with meth use in that group. This is not a general-population meth use rate.[13]
These findings support making stimulant treatment accessible in rural communities and addressing opioid and stimulant use together when both are present. They are useful for planning services, not for predicting whether a particular rural resident will use meth.[12][13][2]
Meth Purity and Crystal Meth Statistics
What Federal Meth Purity Testing Shows
Methamphetamine tested in federal trafficking cases in fiscal year 2022 averaged more than 90% purity, with a median purity of 98%, according to a U.S. Sentencing Commission report released in 2024.[17] This provides strong evidence of high purity in the tested federal case samples.[17]
It does not establish the average purity of every street purchase. Federal trafficking cases are a selected sample, and testing practices varied by jurisdiction. These results should not be presented as a representative national retail-drug survey.[17]
What Meth Purity Does and Does Not Tell You
Purity describes a sample’s composition, not whether it is safe. A high-purity finding does not establish a safe amount to use or tell someone exactly what’s in meth they obtain. The federal testing results also do not answer how often a particular street product contains an unexpected substance.[17]
Meth Treatment Admissions and Getting Help
Treatment Admissions for Meth Increased
A national analysis covering 2010 through 2019 found increases in treatment admissions indicating methamphetamine use. Admissions measure entries into care, however, not the number of unique people recovering or the percentage who remain in recovery over time.[11]
Los Angeles County research also found increasing meth-related treatment episodes across gender and racial or ethnic groups. Compared with people treated for other drugs, those using meth had lower treatment-completion rates and received services from programs with fewer financial and culturally responsive resources. Treatment outcomes therefore need to be understood alongside the care people could access.[9]
What Is the Meth Addiction Recovery Rate?
There is no single meth addiction recovery percentage that these studies can establish. Entering treatment, completing a program, having negative drug tests, and maintaining recovery over years are different outcomes. A result also depends on who received treatment and how long researchers followed them.[9][16]
For example, the ADAPT-2 trial studied injectable naltrexone plus oral bupropion in adults with moderate or severe methamphetamine use disorder over 12 weeks. It enrolled 403 participants in the first stage; 225 placebo nonresponders entered the second stage.[16] These were sequential stages, not separate groups whose counts should be added together.[16]
The weighted response was 13.6% with the medication combination versus 2.5% with placebo.[16] Response meant at least three meth-negative urine samples out of four collected at the end of either stage. That is evidence of a short-term treatment benefit, not a measurement of long-term recovery or an estimate of everyone’s chances of recovery.[16]
What Recovery From Meth Addiction Looks Like
CDC’s 2025 report noted that no FDA-approved medication treatment existed for stimulant use disorder. That does not mean medication can never help. In the naltrexone-bupropion trial, the short-term urine-test response was low but higher with the medication combination than with placebo. CDC called for further evaluation of medication-based treatments.[2][16]
Contingency management has the strongest evidence for stimulant use disorder. It provides positive incentives for recovery-related behaviors, such as verified drug-negative tests. This gives people concrete reinforcement for progress rather than relying only on motivation or willpower.[2][18]
Cognitive behavioral therapy and relapse-prevention work can add practical skills for handling cravings, refusing substances, solving problems, and responding to a return to use. SAMHSA describes these approaches as having some support, particularly when combined with contingency management. Evidence for CBT alone is mixed, and its effectiveness remains unclear.[18]
When contacting a treatment program, useful questions include:
- Do you offer contingency management? Ask what behaviors are reinforced and how the program works.
- How do you address other substance use? If opioids or other drugs are involved, ask how their treatment will be coordinated with meth treatment.
- What mental and physical health support is available? Discuss sleep, mood, psychosis symptoms, and heart-related concerns rather than treating them as separate from recovery.
- How will we measure progress? Ask what outcomes the program tracks and over what period, so a completion rate is not mistaken for a long-term recovery rate.
These questions turn the statistics into a practical next step: finding care with evidence-based treatment, support for related health needs, and a clear way to recognize progress.[2][18]
Support can start with a conversation about your goals and what has been getting in the way.
Frequently asked questions
How Many People Use Meth in the United States?
About 2.7 million people aged 12 or older reported past-year methamphetamine use in 2025, or 0.9% of the U.S. civilian, noninstitutionalized population in that age range.[14] This estimate includes anyone reporting use during the previous year; it does not mean all of them used meth daily or had methamphetamine use disorder.[14]
How Common Is Meth Addiction in the United States?
The 2025 national survey estimated that 1.807 million people aged 12 or older met criteria for past-year methamphetamine use disorder, representing 0.6% of that population.[15][14] The estimate is based on survey responses meeting DSM-5 criteria, not a count of people diagnosed in treatment. It is different from the larger number reporting any past-year meth use.[15][14]
How Many Meth Overdose Deaths Happen Each Year?
CDC’s 2025 report cites 34,855 U.S. overdose deaths involving psychostimulants with abuse potential in 2023.[2] That category primarily involves methamphetamine but includes other amphetamines, so it is not an exact meth-only death count. CDC also noted provisional declines in stimulant-involved deaths in 2024 after substantial increases over earlier years.[2]
What Do Recent Surveys Show About Meth Use Trends?
National past-year meth use prevalence showed no statistically significant change from 2021 through 2025. Earlier research found a 43% increase among adults aged 18 to 64 between 2015 and 2019.[14][1] Those findings describe different periods and populations; survey methodology changes mean the older estimates cannot be directly compared with the series beginning in 2021.[14][1]
Which Groups Are Most Affected by Meth?
The answer depends on the outcome. Past-year use was highest among adults aged 26 or older in the 2025 national survey. A separate analysis found higher use among males than females in 2022, while research using earlier adult survey data found higher use among lesbian, gay, and bisexual adults than heterosexual adults.[14][5][8]
For fatal overdoses, non-Hispanic American Indian and Alaska Native people had the highest psychostimulant death rate among the groups in CDC’s 2018–2023 analysis. These population differences help guide services; they do not predict an individual’s behavior or future.[2]
How Common Is Meth Use Among Teenagers?
About 32,000 adolescents aged 12 to 17 reported past-year methamphetamine use in 2025, representing 0.1% of adolescents.[14] This percentage showed no statistically significant change from 2021 through 2025. Teen use was less common than use among adults, but any teen experiencing meth-related problems deserves timely support.[14]
How Pure Is Street Meth Today?
Federal testing demonstrates high purity in selected methamphetamine samples, but it does not establish a nationwide street-purchase average. Meth tested in federal trafficking cases in fiscal year 2022 averaged more than 90% purity, with a median of 98%.[17] The samples came from selected cases, and testing varied by jurisdiction; those results cannot determine the contents or safety of a particular purchase.[17]
Where Is Meth Use Most Common in the US?
The research here establishes regional overdose patterns rather than a current ranking of use prevalence. By 2021, methamphetamine predominated among substances co-involved with fentanyl in fatal overdoses throughout the West and in most Southern and Midwestern states. Cocaine-fentanyl co-involvement predominated in the Northeast. These death patterns do not identify which state has the highest percentage of residents using meth.[3]
Do Meth Treatment Response Rates Measure Lasting Recovery?
No single percentage from these studies describes everyone’s chance of recovery. Treatment completion, negative drug tests, and sustained recovery measure different outcomes over different periods. For example, the naltrexone-bupropion trial measured a short-term urine-test response, not lifelong recovery.[9][16]
There is evidence that treatment helps. Contingency management has the strongest support for stimulant use disorder. Cognitive behavioral and relapse-prevention approaches focus on skills for managing cravings and coping, and have some support, especially when combined with contingency management. Evidence for CBT alone is mixed. Ask a program which treatments it offers and how it measures progress.[2][18]
What Is the Life Expectancy of Someone With Meth Addiction?
The studies reviewed here do not provide a single life-expectancy estimate for someone with meth addiction. Population overdose rates and hospitalization counts cannot predict an individual’s lifespan. They do show serious, treatable health concerns that deserve attention, including cardiovascular problems and co-occurring substance use. A medical assessment can identify current concerns and connect someone with appropriate care.[2][7]
Get Treatment Help
If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.
Exclusive offer: 20% Off BetterHelp*Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

